Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza - Scott, C; Kankanala, J; Foster, TL; Goldhill, DH; Bao, P; Simmons, K; Pingen, M; Bentham, M; Atkins, E; Loundras, E; Eldertield, R; Claridge, JK; et al. (PLOS PATHOGENS, 2020)